Skip to main content

Table 1 General information

From: Comparison of three digestive tract reconstruction methods for the treatment of Siewert II and III adenocarcinoma of esophagogastric junction: a prospective, randomized controlled study

Variables (n, %)

PJIRSTR

(n = 98)

PJIRDTR

(n = 103)

TGRY

(n = 99)

P value

Male

88 (89.80)

90 (87.38)

82 (82.83)

0.345

Age (years)

   

0.458

 < 60

25 (25.51)

23 (22.33)

18 (18.18)

 

 ≥ 60

73 (74.49)

80 (77.67)

18 (18.18)

 

Differentiation

   

0.572

 High-middle

60 (61.22)

70 (67.96)

66 (66.67)

 

 Low

38 (38.78)

33 (32.04)

33 (33.33)

 

TNM stage

   

0.562

 I

81 (82.65)

87 (84.47)

78 (78.79)

 

 II

17 (17.35)

16 (15.53)

21 (21.21)

 

Siewert type

   

0.628

 II

45 (45.92)

48 (46.60)

40 (40.40)

 

 III

53 (54.08)

55 (53.40)

59 (59.60)

 

Clinical stage

   

0.562

 T1N0M0 stage IA

61 (62.24)

65 (63.11)

63 (63.64)

 

 T2N0M0 stage IB

20 (20.41)

22 (21.36)

15 (15.15)

 

 T3N0M0 stage II

17 (17.35)

16 (15.53)

21 (21.21)